Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient
We hypothesize that this reaction was triggered by azathioprine dose reduction. Dose modification of long-term immunosuppressive medications in patients with a transplantation history who later develop SCCs warrants further investigation.
Authors
- David Gyorki (ORCID: https://orcid.org/0000-0002-3165-4694)
- Jessica Da Gama Duarte (ORCID: https://orcid.org/0000-0003-4289-5204)
- Louise Jackett (ORCID: https://orcid.org/0000-0003-2792-6199)
- John B. Whitlam (ORCID: https://orcid.org/0000-0003-2202-1462)
- Andreas Behren (ORCID: https://orcid.org/0000-0001-5329-280X)
- Luke T. Quigley (ORCID: https://orcid.org/0000-0003-4975-7779)
- Tegan Ormston
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- La Trobe University (AU)
- Peter MacCallum Cancer Centre (AU)
- Victorian Clinical Genetics Services (AU)
- Murdoch Children's Research Institute (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
- Austin Health (AU)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.3389/fimmu.2024.1474663
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- U.S. Department of Health and Human Services
- Cancer Research Institute
- David and Elaine Potter Foundation
- Cancer Australia
- State Government of Victoria
- Tour de Cure